News & Events
06/04/214 reasons to use mass spectrometry for newborn screening for sickle cell disease
Mass spectrometry is now widely used in newborn screening laboratories. This technology is proving to be cost-effective and competitive for the detection of sickle cell disease and other hemoglobinopathies in newborns. Here are 4 reasons to adopt this technique.
Targeted, mass spectrometry selects only certain peptides of interest in hemoglobin. It therefore addresses hemoglobinopathies such as sickle cell disease (SCD), other variants of hemoglobin or thalassemia. Here are 4 reasons to use mass spectrometry for newborn screening for sickle cell disease.